Minerva Neurosciences Inc...

NASDAQ: NERV · Real-Time Price · USD
2.26
0.46 (25.91%)
At close: Aug 15, 2025, 3:59 PM
2.32
2.85%
After-hours: Aug 15, 2025, 07:47 PM EDT

Minerva Neurosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
42.22K 42.22K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 41.18M
Cost of Revenue
34.47K 42.22K 28.86K 30.98K 30.98K 30.98K 29.62K 21.88K 14.13K 6.38K n/a 14.94K 58.95K 101.79K 101.79K 86.85K 42.83K
Gross Profit
7.75K n/a -28.86K -30.98K -30.98K -30.98K -23.24K -15.49K -7.75K n/a n/a -14.94K -58.95K -101.79K -101.79K -86.85K 41.13M
Operating Income
-19.07M -21.85M -24.5M -26.21M -24.45M -23.12M -21.02M -20.15M -22.59M -25.23M -41.54M -43.85M -45.85M -45.37M -31.29M -31.86M 6.61M
Interest Income
360.75K 718.66K 1.08M 1.43M 1.43M 1.44M 1.64M 1.47M 1.17M 816.83K 263.58K 87.64K 19.83K 16.52K 12.82K 8.67K 4.1K
Pretax Income
6.25M 1.44M -3.31M -33.64M -31.6M -30M -27.71M -26.79M -29.31M -32.11M -48.49M -50.8M -52.67M -51.71M -35.92M -34.83M 5.29M
Net Income
6.25M 1.44M -3.31M -33.64M -31.6M -30M -27.71M -26.79M -29.24M -32.03M -46.62M -48.92M -50.87M -49.91M -35.92M -34.83M 5.29M
Selling & General & Admin
9.96M 9.93M 9.83M 10M 10.22M 10.41M 9.84M 10.05M 10.25M 10.58M 11.33M 11.5M 12.11M 13.33M 14.44M 14.89M 17.35M
Research & Development
9.09M 11.9M 14.64M 16.19M 14.22M 12.71M 11.18M 10.1M 12.34M 14.65M 30.2M 32.35M 33.74M 32.04M 16.84M 16.97M 17.22M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
19.05M 21.83M 24.47M 26.19M 24.44M 23.11M 21.02M 20.15M 22.59M 25.23M 41.54M 43.85M 45.85M 45.37M 31.29M 31.86M 34.56M
Interest Expense
2.31M 4.56M 6.75M 8.84M 8.55M 8.28M 8.02M 7.81M 7.6M 7.41M 7.21M 7.02M 6.81M 6.33M 4.59M 2.91M 1.3M
Selling & Marketing Expenses
2,514.7B 2,514.7B -4,895.9B -2,417.1B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
10.03M 12.8M 24.5M 26.21M 24.45M 23.12M 21.02M 20.15M 22.59M 25.23M 41.54M 43.85M 45.85M 45.37M 31.29M 31.86M 34.56M
Income Tax Expense
4.00 -1 -1 -7.75K -7.75K -7.75K -7.75K n/a -73.97K -77.6K -1.88M -1.88M -1.81M -1.8M 25.34K 47.67K 26.39K
Shares Outstanding (Basic)
7.57M 7.57M 7.57M 7.57M 7.57M 7.57M 7.57M 5.51M 5.34M 5.34M 5.34M 5.34M 5.34M 5.34M 5.34M 5.34M 5.34M
Shares Outstanding (Diluted)
7.57M 7.57M 7.57M 7.57M 7.57M 7.57M 7.57M 5.51M 5.34M 5.34M 5.34M 5.34M 5.34M 5.34M 5.34M 5.34M 5.34M
EPS (Basic)
0.82 0.19 -0.44 -4.44 -4.47 -4.65 -4.72 -5.3 -5.8 -6.32 -9.05 -9.16 -9.52 -9.34 -6.75 -6.58 1.40
EPS (Diluted)
0.82 0.19 -0.44 -4.44 -4.47 -4.65 -4.72 -5.3 -5.8 -6.32 -9.05 -9.16 -9.52 -9.34 -6.75 -6.58 1.24
EBITDA
8.58M 6.02M 3.47M -24.78M -23.02M -21.69M -19.66M -18.96M -21.69M -24.69M -41.28M -43.76M -45.8M -45.28M -31.16M -31.72M 6.74M
EBIT
8.57M 6M 3.44M -24.81M -23.05M -21.72M -19.69M -18.98M -21.71M -24.7M -41.28M -43.77M -45.86M -45.38M -31.3M -31.9M 6.61M
Depreciation & Amortization
16.09K 22.47K 28.86K 30.98K 30.98K 30.98K 29.62K 24K 102.32K 90.95K 84.13K 96.94K 54.89K 101.34K 146.38K 176.36K 176.19K